Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income	Total New Residential Stockholders’ Equity	Noncontrolling Interests in Equity of Consolidated Subsidiaries	Common Stock	Common Stock Common Stock	Common Stock Additional Paid-in Capital	Common Stock Total New Residential Stockholders’ Equity	Preferred Stock	Preferred Stock Preferred Stock	Preferred Stock Total New Residential Stockholders’ Equity	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Retained Earnings (Accumulated Deficit)	Cumulative Effect, Period of Adoption, Adjustment Total New Residential Stockholders’ Equity	Cumulative Effect, Period of Adoption, Adjustment Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2019		17,510,000	415,520,780
Equity, beginning balance at Dec. 31, 2019	$ 7,236,260	$ 423,444	$ 4,156	$ 5,498,226	$ 549,733	$ 682,151	$ 7,157,710	$ 78,550								$ 30,453	$ 13,658	$ 13,658	$ 16,795
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(20,782)				(20,782)		(20,782)
Dividends declared on preferred stock	(11,222)				(11,222)		(11,222)
Capital distributions	(12,605)							(12,605)
Issuance of stock (in shares)										97,394				16,100,000
Issuance of stock									$ 1,583	$ 1	$ 1,582	$ 1,583	$ 389,548	$ 389,548	$ 389,548
Director share grants (in shares)			31,040
Director share grants	500			500			500
Comprehensive income (loss)
Net income (loss)	(1,607,255)				(1,591,093)		(1,591,093)	(16,162)
Unrealized gain (loss) on available-for-sale securities, net	34,375					34,375	34,375
Reclassification of realized (gain) loss on available-for-sale securities, net into earnings:	(710,391)					(710,391)	(710,391)
Comprehensive income (loss)	(2,283,271)						(2,267,109)	(16,162)
Equity, ending balance (in shares) at Mar. 31, 2020		33,610,000	415,649,214
Equity, ending balance at Mar. 31, 2020	5,330,464	$ 812,992	$ 4,157	5,500,308	(1,059,706)	6,135	5,263,886	66,578
Equity, beginning balance (in shares) at Dec. 31, 2020		33,610,000	414,744,518
Equity, beginning balance at Dec. 31, 2020	5,429,684	$ 812,992	$ 4,148	5,547,108	(1,108,929)	65,697	5,321,016	108,668
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(82,959)				(82,959)		(82,959)
Dividends declared on preferred stock	(14,358)				(14,358)		(14,358)
Capital distributions	(19,078)							(19,078)
Director share grants (in shares)			52,745
Director share grants	500		$ 1	499			500
Comprehensive income (loss)
Net income (loss)	301,336				291,942		291,942	9,394
Unrealized gain (loss) on available-for-sale securities, net	8,565					8,565	8,565
Reclassification of realized (gain) loss on available-for-sale securities, net into earnings:	(1,877)					(1,877)	(1,877)
Comprehensive income (loss)	308,024						298,630	9,394
Equity, ending balance (in shares) at Mar. 31, 2021		33,610,000	414,797,263
Equity, ending balance at Mar. 31, 2021	$ 5,621,813	$ 812,992	$ 4,149	$ 5,547,607	$ (914,304)	$ 72,385	$ 5,522,829	$ 98,984